The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims

被引：0
|
作者：
Tabah, Ashley [1 ]
Huggar, David [1 ]
Brady, Brenna L. [2 ]
Jariwala-Parikh, Krutika [3 ]
Huey, Krystal [1 ]
Copher, Ronda M. [1 ]
Leblanc, Thomas W. [4 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] IBM Watson Hlth, Bethesda, MD USA
[3] IBM Watson Hlth, Ann Arbor, MI USA
[4] Duke Canc Inst, Durham, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
AML; acute myeloid leukemia; healthcare resource utilization; cost; relapse;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-117
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [1] Economic Burden of Treatment Episodes in Acute Myeloid Leukemia (AML) Patients in the US: A Retrospective Analysis of a Commercial Payer Database
    Medeiros, Bruno C.
    Pandya, Bhavik J.
    Chen, Chi-Chang
    Groves, Eric S.
    Bui, Cat N.
    Horvath, Laura Elise
    Wade, Rolin L.
    [J]. BLOOD, 2017, 130
  • [2] ECONOMIC BURDEN OF ACUTE MYELOID LEUKEMIA RELAPSE IN US PATIENTS
    Potluri, R.
    Papademetriou, E.
    Kiendrebeogo, Z. N.
    Liu, X.
    Chen, C.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S388 - S388
  • [3] ECONOMIC BURDEN OF RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): A RETROSPECTIVE CLAIMS-BASED ANALYSIS
    Griffin, J.
    Shah, M., V
    Song, Y.
    Yang, H.
    Tang, W.
    [J]. VALUE IN HEALTH, 2019, 22 : S468 - S468
  • [4] Economic Burden of Hospitalizations for Acute Myeloid Leukemia (AML) in Remission in the United States: A Retrospective Analysis of an Administrative Claims Database
    Chen, Clara
    Papademetriou, Eros
    Liu, Xing
    Potluri, Ravi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S284 - S284
  • [5] Acute Myeloid Leukemia (AML): A Retrospective Claims Analysis of Resource Utilization and Expenditures
    Irish, William D.
    Ryan, Michael
    Gache, Larry
    Gunnarsson, Candace
    Bell, Timothy
    Shapiro, Mark
    [J]. BLOOD, 2015, 126 (23)
  • [6] Economic Burden of Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) in the US
    Aly, Abdalla
    Bapat, Bela
    Ray, Saurabh
    Chen, Zhiyong
    Botteman, Marc
    [J]. BLOOD, 2017, 130
  • [7] Economic and Clinical Burden of Relapsed and/or Refractory Active Treatment Episodes in Patients with Acute Myeloid Leukemia (AML) in the USA: A Retrospective Analysis of a Commercial Payer Database
    Bhavik J. Pandya
    Chi-Chang Chen
    Bruno C. Medeiros
    Catherine B. McGuiness
    Samuel Wilson
    L. Elise Horvath Walsh
    Rolin L. Wade
    [J]. Advances in Therapy, 2019, 36 : 1922 - 1935
  • [8] Economic and Clinical Burden of Relapsed and/or Refractory Active Treatment Episodes in Patients with Acute Myeloid Leukemia (AML) in the USA: A Retrospective Analysis of a Commercial Payer Database
    Pandya, Bhavik J.
    Chen, Chi-Chang
    Medeiros, Bruno C.
    McGuiness, Catherine B.
    Wilson, Samuel
    Walsh, L. Elise Horvath
    Wade, Rolin L.
    [J]. ADVANCES IN THERAPY, 2019, 36 (08) : 1922 - 1935
  • [9] Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database
    Pandya, Bhavik J.
    Chen, Chi-Chang
    Medeiros, Bruno C.
    McGuiness, Catherine B.
    Wilson, Samuel D.
    Walsh, Elise Horvath
    Wade, Rolin L.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (07): : 849 - 859
  • [10] Treatment patterns, economic burden, and overall survival in US Medicare Advantage beneficiaries newly diagnosed with acute myeloid leukemia (AML) in 2015-2020
    Huntington, Scott F.
    Ingham, Michael P.
    Okonkwo, Linda
    Singh, Ajaybir
    Wang, Ruibin
    Ammann, Eric M.
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1180 - 1190
12345